Article · 4 May 2026
ArticlePublished 18 Jan 2024
Study of the Effectiveness of Renshen Yangrong Decoction in Combination with Conventional Drugs in the Treatment of Dilated Cardiomyopathy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
To investigate the effect of Renshen Yangrong decoction combined with conventional drugs in the treatment of dilated cardiomyopathy. 107 patients with dilated cardiomyopathy were divided into a Chinese medicine group (n=54) and a control group (n=53) using the random number table method. Control group received placebo combined with conventional medication and Chinese medicine group received Renshen Yangrong decoction combined with conventional medication. The clinical efficacy, cardiac function indexes, serological indexes, quality of life scores and adverse effects of the two groups were compared. The overall treatment efficiency of Chinese medicine group was higher than that of control group (p<0.05). After treatment, Chinese medicine group had higher left ventricular ejection fraction, blood volume, serum N-terminal pro-B-type natriuretic peptide, serum procollagen type I carboxy-terminal peptide, serum procollagen type III carboxy-terminal peptide and all Minnesota heart failure quality of life scale scores than control group (p<0.05) and the left ventricular end-diastolic diameter was lower than control group (p<0.05). No adverse events occurred in either group. Renshen Yangrong decoction combined with conventional drugs is safe and effective in the tr eatment of dilated cardiomyopathy.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Xiangyu. Meng”
- BylineArticles whose byline prints “Yue Du”
- BylineArticles whose byline prints “Chengjie Song”
- BylineArticles whose byline prints “Zhilin Cui”